A Combined Assessment Method of Phase Angle and Skeletal Muscle Index to Better Predict Functional Recovery after Acute Stroke

Abe, Tokiharu; Yoshimua, Yoshihiro; Imai, Ryota; Sato, Yoichi

doi:10.1007/s12603-022-1777-9

Cited by 13 publications

(5 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Sarcopenia negatively affects clinical outcomes in patients with stroke. The prevalence of sarcopenia in stroke patients in acute hospitals has been reported to be 8.5–33.8% [ 12 , 13 , 14 , 15 , 16 ], and sarcopenia leads to unfavorable outcomes 90 days after stroke [ 15 ]. In post-acute rehabilitation hospitals, approximately 50% of patients suffer from sarcopenia on admission [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ], and sarcopenia inhibits functional recovery and return to home in patients with stroke [ 25 ].…”

Section: Introductionmentioning

confidence: 99%

Trajectories of the Prevalence of Sarcopenia in the Pre- and Post-Stroke Periods: A Systematic Review

Inoue

Ueshima

Kawase³

et al. 2022

Nutrients

View full text Add to dashboard Cite

Interventions for stroke-related sarcopenia in patients with stroke are needed, but the details of the target population are unclear. This systematic review aimed to identify trajectories of the prevalence of sarcopenia in the pre- and post-stroke periods and to determine the diagnostic criteria used in patients with stroke. We searched for literature in six databases: MEDLINE, EMBASE, Web of Science, Cochrane Central Register of Controlled Trials, CINAHL, and Ichushi-web (in Japanese). We included 1627 studies in the primary screening, and 35 studies were finally included. Of the 35 studies, 32 (91.4%) included Asian patients, and the criteria of the Asian Working Group for Sarcopenia was mainly used as the diagnostic criteria. Nineteen studies used muscle strength and muscle mass to diagnose sarcopenia, whereas a full assessment, including physical performance, was performed in five studies. The estimated prevalences of sarcopenia in pre-stroke, within 10 days of stroke, and from 10 days to 1 month after stroke were 15.8%, 29.5%, and 51.6%, respectively. Sarcopenia increased by approximately 15% from pre-stroke to 10 days, and increased by approximately 20% from 10 days to 1 month. Healthcare providers should note that the prevalence of sarcopenia increases during the acute phase in patients with stroke.

show abstract

Section: Introductionmentioning

confidence: 99%

Trajectories of the Prevalence of Sarcopenia in the Pre- and Post-Stroke Periods: A Systematic Review

Inoue

Ueshima

Kawase³

et al. 2022

Nutrients

View full text Add to dashboard Cite

show abstract

“…[ 1 , 41 ] SMI is calculated as appendicular skeletal muscle mass divided by height squared (kg/m 2 ),and the cutoff points for men is SMI < 7.0 kg/m 2 , for women is SMI < 5.7 kg/m 2 . [ 1 ] Abe et al [ 42 ] confirmed that low PA and SMI was independently and negatively associated with functional recovery in patients with acute stroke.…”

Section: Observationsmentioning

confidence: 99%

Advances in the beneficial effects of nutrition on stroke-related Sarcopenia: A narrative review

Gao

Chen

2023

Medicine

View full text Add to dashboard Cite

Stroke is one of the most common causes of disability in adults. Sarcopenia is a syndrome characterized by progressive systemic muscle loss and functional decline. The decrease in skeletal muscle mass and muscle function throughout the body after stroke cannot be explained by neurological motor disorders due to brain injury alone, it is considered to be a secondary sarcopenia known as stroke-related sarcopenia. Mounting evidences showed that stroke-related sarcopenia might promote the occurrence and development of sarcopenia through various pathogenesis such as muscle atrophy, dysphagia, inflammation, and malnutrition, etc. At present, the main indicators used to assess malnutrition in patients with stroke-related sarcopenia include temporalis muscle thickness, calf circumference, phase angle, geriatric nutritional risk index and mini-nutritional assessment short-form, etc. Currently, there is no particularly effective method to curb its progression, but supplementation with essential amino acids, whey protein combined with vitamin D, high energy diet, avoiding Polypharmacy, as well as increasing physical activity level and reducing sedentary lifestyle may improve the malnutrition status of stroke patients, and increase the muscle mass and skeletal muscle index, further delay or even prevent the development of stroke-related sarcopenia. This article reviews the latest research progress on the characteristics, epidemiology, pathogenesis and the role of nutrition in stroke-related sarcopenia, so as to provide reference for the clinical treatment and rehabilitation of stroke-related sarcopenia.

show abstract

“…It is considered a promising tool for clinical prognostic assessment. In various clinical conditions, BIA parameters such as PA is associated with several clinical outcomes including: functional status at discharge in acute stroke patients [ 15 ]; short-term outcomes and long-term survival in breast cancer, pancreatic cancer and colorectal cancer patients post-surgery [ [16] , [17] , [18] ]; frailty mortality, morbidity, and length hospital of stay in patients after major cardiac surgery [ 19 ]. In the intensive care unit (ICU) setting, PA and ECW/TBW are associated with worse clinical outcomes such as mortality rate and length of ICU stay [ [20] , [21] , [22] ].…”

Section: Introductionmentioning

confidence: 99%

Association of bioimpedance analysis parameters trajectories with clinical outcomes in neurocritical patients

Peng,

Yang,

2024

Heliyon

View full text Add to dashboard Cite

A Combined Assessment Method of Phase Angle and Skeletal Muscle Index to Better Predict Functional Recovery after Acute Stroke

Cited by 13 publications

References 39 publications

Trajectories of the Prevalence of Sarcopenia in the Pre- and Post-Stroke Periods: A Systematic Review

Trajectories of the Prevalence of Sarcopenia in the Pre- and Post-Stroke Periods: A Systematic Review

Advances in the beneficial effects of nutrition on stroke-related Sarcopenia: A narrative review

Association of bioimpedance analysis parameters trajectories with clinical outcomes in neurocritical patients

Contact Info

Product

Resources

About